Device Week, April 5, 2019 – A Trio Of FDA Guidance Docs To Keep An Eye On

Citeline Podcasts

English - April 05, 2019 16:54 - 8 minutes - 16.3 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Device Week, March 29, 2019 –UK Oxfordshire Wants To Become Digital-Health Hub,Trials and Innovation

Next Episode: Device Week, April 10, 2019 - Alcon Is Finally Free From Novartis; EOS Promotes 3D Ortho-Imaging

In this week’s podcast, Medtech Insight journalists Shawn M. Schmitt, Ferdous Al-Faruque and Elizabeth Orr discuss a recent flurry of guidance document news from US FDA on facility inspections, artificial intelligence and anthrax detection devices.
Medtech Insight articles addressing topics discussed in this episode:
• With Fresh Guidance, US FDA Aims For Consistency In Device Facility Inspections (https://protect-us.mimecast.com/s/fbN6CQWNOwhkRVZoLsPtuEU?domain=medtech.pharmaintelligence.informa.com)
• Rise Of The Machines: FDA Artificial Intelligence Guidance Is Coming (https://protect-us.mimecast.com/s/BJD-CR6MLxfvOYZ5XTPiIw3?domain=medtech.pharmaintelligence.informa.com)
• After Years Of Waiting, FDA Classifies Anthrax Detection Devices As Class II (https://protect-us.mimecast.com/s/cBW0CVO5NBcxZBQg8sJEbEK?domain=medtech.pharmaintelligence.informa.com)